3-alpha (17-beta)-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide+)
RxNorm 1748610
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1748610 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 3-alpha (17-beta)-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide+).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
3-alpha (17-beta)-hydroxysteroid dehydrogenase (NAD+)
(Atom ID: 504086)
SY
Synonym (SY):
3-alpha (17-beta)-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide+)
(Atom ID: 5939128)
FN
Full form of descriptor (FN):
3-alpha (17-beta)-hydroxysteroid dehydrogenase (nicotinamide adenine dinucleotide+) (substance)
(Atom ID: 5939129)
PT
Designated preferred name (PT):
Testosterone 17beta-dehydrogenase
(Atom ID: 728747)
FN